IDSA GUIDELINES Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America John R. Perfect,1 William E. Dismukes,2 Francoise Dromer,11 David L. Gol

First Page		Document Content
Date: 2011-08-14 19:11:17 Microbiology Organofluorides Triazoles Fungal diseases Yeasts Cryptococcus neoformans Flucytosine Cryptococcosis Fluconazole Antifungals Chemistry Biology		IDSA GUIDELINES Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America John R. Perfect,1 William E. Dismukes,2 Francoise Dromer,11 David L. Gol Add to Reading List Source URL: www.idsociety.org Download Document from Source Website File Size: 444,50 KB Share Document on Facebook

	article published online: 1 june 2015 \| doi: nchembio.1821 Nontoxic antimicrobials that evade drug resistance Stephen A Davis1,2, Benjamin M Vincent3,4, Matthew M Endo1,2, Luke Whitesell4, Karen Marchillo5,6, Dav DocID: 1pvkH - View Document
	ISHAM WORKING GROUP APPLICATION FORM Name of the proposed the Working Group AIDS-related Mycoses Working Group Name(s) of coordinator(s), including title, proposing the working group Dr. Tihana Bicanic (Lead coordinator) DocID: 1ofJA - View Document
	PDF Document DocID: 1avLk - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PEGINTRON safely and effectively. See full prescribing information for PEGINTRON. ® DocID: 1a7vQ - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION DocID: 19TOt - View Document